Interview with Dr Bonnie Glisson on the combination trial of ISA101 and Nivolumab

21 Sep 2017

Please find below a link to an interview taken during ESMO in Madrid with Dr Bonnie Glisson on the combination trial of ISA101 and Nivolumab (aPD1) in SCCHN patients run at MD Anderson Cancer Center:
http://www.ascopost.com/videos/2017-esmo-congress/bonnie-s-glisson-md-on-hpv-16plus-cancer-study-results/

Previous
Next